Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1987 1
1988 1
2002 1
2003 2
2004 1
2005 1
2007 2
2008 1
2009 1
2010 1
2011 1
2012 2
2015 3
2016 2
2017 1
2018 3
2019 2
2020 1
2021 14
2022 23
2023 14
2024 19
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. Among authors: carr dr. N Engl J Med. 2025 Aug 21;393(8):774-785. doi: 10.1056/NEJMoa2502449. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454639 Clinical Trial.
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma.
Jambusaria-Pahlajani A, Jeanselme V, Wang DM, Ran NA, Granger EE, Cañueto J, Brodland DG, Carr DR, Carter JB, Carucci JA, Hirotsu KE, Karn EE, Koyfman SA, Mangold AR, Muradás Girardi F, Shahwan KT, Srivastava D, Vidimos AT, Willenbrink TJ, Wysong A, Lotter W, Ruiz ES. Jambusaria-Pahlajani A, et al. Among authors: carr dr. J Am Acad Dermatol. 2025 Jul;93(1):73-81. doi: 10.1016/j.jaad.2025.02.076. Epub 2025 Feb 28. J Am Acad Dermatol. 2025. PMID: 40024391
Metastatic Spiradenocarcinoma Managed With PD-1 Inhibition.
Wargo JJ, Carr DR, Plaza JA, Verschraegen CF. Wargo JJ, et al. Among authors: carr dr. J Natl Compr Canc Netw. 2022 Feb 23:1-3. doi: 10.6004/jnccn.2021.7119. Online ahead of print. J Natl Compr Canc Netw. 2022. PMID: 35196645
Off-label uses of rituximab in dermatology.
Carr DR, Heffernan MP. Carr DR, et al. Dermatol Ther. 2007 Jul-Aug;20(4):277-87. doi: 10.1111/j.1529-8019.2007.00141.x. Dermatol Ther. 2007. PMID: 17970893 Review.
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC.
Cheraghlou S, Stevenson ML, Christensen SR, Bordeaux JS, Walker JL, Srivastava D, Ferrándiz-Pulido C, Bibee KP, Carter JB, Samie FH, Patel VA, Carroll BT, Vidimos AT, Baum CL, Leitenberger JJ, Jambusaria-Pahlajani A, Ruiz ES, Carucci JA, Carr DR, Shahwan KT. Cheraghlou S, et al. Among authors: carr dr. JAMA Dermatol. 2024 Sep 1;160(9):989-992. doi: 10.1001/jamadermatol.2024.2242. JAMA Dermatol. 2024. PMID: 39046711
Hyperpigmented nodule on a young Black man.
Hodge DT, Shipp D, Carr DR. Hodge DT, et al. Among authors: carr dr. JAAD Case Rep. 2022 Jul 4;27:153-155. doi: 10.1016/j.jdcr.2022.05.044. eCollection 2022 Sep. JAAD Case Rep. 2022. PMID: 36090385 Free PMC article. No abstract available.
A multicenter validation study of Mohs micrographic surgery versus wide local excision in primary high-stage cutaneous squamous cell carcinoma.
Wang DM, Ran NA, Granger EE, Koyfman S, Vidimos A, Wysong A, Carr DR, Shahwan KT, Hirotsu KE, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Srivastava D, Nijhawan RI, Brodland DG, Zitelli JA, Willenbrink TJ, Ruiz ES. Wang DM, et al. Among authors: carr dr. J Am Acad Dermatol. 2025 Aug;93(2):527-532. doi: 10.1016/j.jaad.2025.04.010. Epub 2025 Apr 8. J Am Acad Dermatol. 2025. PMID: 40210096 No abstract available.
110 results